Dicloxacillin Sodium Oral Capsule 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Dicloxacillin Sodium: Oral capsule (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2417.JPG
Dicloxacillin 250mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: TEVA 3123 

What is this Medicine?

DICLOXACILLIN (dye klox a SILL in) is a penicillin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

CVS Pharmacy Patient Statistics for Dicloxacillin Sodium: Oral capsule(250mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Dicloxacillin Sodium 250mg Capsule

NDC: 000933123
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bacteremia, Pneumonia, Impetigo, Bone And Joint Infections, Endocarditis, Skin And Skin Structure Infections, Infectious Arthritis, Osteomyelitis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Dicloxacillin Sodium 250mg Capsule
Drug Image file DrugItem_2417.JPG
Teva Pharmaceuticals USA Inc
Pill Identification: TEVA 3123 
Shape: capsule
Color: green

Reported Side Effects for Dicloxacillin Sodium 250mg Capsule

Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Tongue Discoloration Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Kidney Damage Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Vocal Cord Spasm Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Laryngeal Edema Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Breathing Difficulties Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Anaphylactoid Reactions Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Severe Allergy Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Joint Pain Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<0.1%*
Severity: MODERATE
Onset: RAPID
Muscle Pain Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Protein In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Serum Sickness Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pseudomembranous Colitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Dicloxacillin Sodium

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5